Author(s):
Uppara Venkatesh, B. V. Ramana
Email(s):
ukvenkatesh053@gmail.com
DOI:
10.52711/0974-360X.2025.00220
Address:
Uppara Venkatesh*1,2, B. V. Ramana3
1Research Scholar, Jawaharlal Nehru Technological University Anantapur, Ananthapuramu, India.
2Department of Pharmacology, St. Johns College of Pharmaceutical Sciences, Yerrakota, Yemmiganur, Kurnool Dist. India. Affiliated to Jawaharlal Nehru Technological University Anantapur, Ananthapuramu.
3Dr. K. V. Subba Reddy Institute of Pharmacy, Kurnool, India. Affiliated to Jawaharlal Nehru Technological University Anantapur, Ananthapuramu.
*Corresponding Author
Published In:
Volume - 18,
Issue - 4,
Year - 2025
ABSTRACT:
Hepatotoxicity and renal failure are two of the major complications of diabetes mellitus, among its numerous other complications. The primary cause of liver and kidney problems is the oxidative stress that is brought on by persistently high blood sugar levels. The current study aimed to assess the possible hepatic and nephron protective roles of a novel anti-diabetic poly herbal preparation containing dried leaves of Tinospora cordifolia, dried bark of Cinnamomum zeylanicum, dried seeds of Trigonella foenum, and dried seeds of Nigella sativa in streptozotocin (STZ) induced diabetic rats. Experimentally diabetes in Albino rats was induced by using streptozotocin. By examining several biochemical indicators to gauge their impact on the liver and kidney, diabetic rats were tested against an in-house prepared novel poly herbal formulation. Hepatic glycogen (HG), serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), alkaline phosphatase (ALP), total proteins (TP), total bilirubin (TB), direct (DB) and indirect bilirubin (IB), albumin, and globulin were used to measure the hepatoprotective efficacy. Blood urea nitrogen (BUN), urea, uric acid, and creatinine were used as kidney function markers to assess the nephroprotective potential. Six rats were placed in each of the thirteen groups, ethanolic extract polyherbal preparation was chosen for further testing of its hepatoprotective and nephroprotective potentials since it significantly reduced blood glucose levels in our prior trials. In streptozotocin-induced diabetic albino rats, the impaired liver and kidney functions significantly improved. The presence of active phytochemical ingredients may be the cause of the reversal of hepatic renal biochemical changes. Accordingly, the study came to the conclusion that the poly herbal combination (EHPH) efficiently heals diabetes-related liver and renal issues as well as prevents subsequent difficulties.
Cite this article:
Uppara Venkatesh, B. V. Ramana. Assessment of Hepatoprotective and Nephroprotective potentials of a Novel Anti-diabetic Poly Herbal Preparation. Research Journal of Pharmacy and Technology. 2025;18(4):1535-3. doi: 10.52711/0974-360X.2025.00220
Cite(Electronic):
Uppara Venkatesh, B. V. Ramana. Assessment of Hepatoprotective and Nephroprotective potentials of a Novel Anti-diabetic Poly Herbal Preparation. Research Journal of Pharmacy and Technology. 2025;18(4):1535-3. doi: 10.52711/0974-360X.2025.00220 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-4-11
REFERENCES:
1. Clements Jr RS, Bell DS. Complications of diabetes: prevalence, detection, current treatment, and prognosis. The American Journal of Medicine. 1985; Nov 15; 79(5): 2-7. DOI: https://doi.org/10.1016/0002-9343(85)90503-0
2. Soumya D, Srilatha B. Late stage complications of diabetes and insulin resistance. J Diabetes Metab. 2011; Dec 25; 2(9): 1000167. DOI: http://dx.doi.org/10.4172/2155-6156.1000167
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013; Jan 1; 36(Supplement_1): S67-74. DOI: https://doi.org/10.2337/dc10-S062
4. Castano L, Eisenbarth GS. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annual Review of Immunology. 1990; Apr; 8(1): 647-79. DOI: https://doi.org/10.1146/annurev.iy.08.040190.003243
5. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. The Lancet. 2017; Jun 3; 389(10085): 2239-51. DOI: https://doi.org/10.1016/S0140-6736(17)30058-2
6. Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International. 2002; Mar 1; 61(3): 1086-97. DOI: https://doi.org/10.1046/j.1523-1755.2002.00213.x
7. Cusick M, Meleth AD, Agrón E, Fisher MR, Reed GF, Knatterud GL, Barton FB, Davis MD, Ferris III FL, Chew EY, Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group. Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27. Diabetes Care. 2005; Mar 1; 28(3):617-25. DOI: https://doi.org/10.2337/diacare.28.3.617
8. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clinical Diabetes. 2008 Apr 1;26(2):77-82. Available on: https://cmbdiabetes.wdfiles.com/local--files/reference/complications_diabetes.pdf
9. Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?. Diabetologia. 2008; Nov; 51: 1947-53. DOI: https://doi.org/10.1007/s00125-008-1135-4
10. Tanase DM, Gosav EM, Anton MI, Floria M, Seritean Isac PN, Hurjui LL, Tarniceriu CC, Costea CF, Ciocoiu M, Rezus C. Oxidative stress and NRF2/KEAP1/ARE pathway in diabetic kidney disease (DKD): new perspectives. Biomolecules. 2022; Sep 2;12(9):1227. DOI: https://doi.org/10.3390/biom12091227
11. Beckman JA, Creager MA. Vascular complications of diabetes. Circulation Research. 2016; May 27; 118(11): 1771-85. DOI: https://doi.org/10.1161/CIRCRESAHA.115.306884
12. Genco RJ, Borgnakke WS. Diabetes as a potential risk for periodontitis: association studies. Periodontology 2000. 2020 Jun;83(1):40-5. DOI: https://doi.org/10.1111/prd.12270
13. Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, Bikbov MM, Wang YX, Tang Y, Lu Y, Wong IY. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021; Nov 1; 128(11): 1580-91. DOI: https://doi.org/10.1016/j.ophtha.2021.04.027
14. Robert AA, Al Dawish MA. The worrying trend of diabetes mellitus in Saudi Arabia: an urgent call to action. Current diabetes reviews. 2020; Mar 1; 16(3): 204-10. DOI: https://doi.org/10.2174/1573399815666190531093735
15. Tinajero MG, Malik VS. An update on the epidemiology of type 2 diabetes: a global perspective. Endocrinology and Metabolism Clinics. 2021; Sep 1; 50(3): 337-55. DOI: https://doi.org/10.1016/j.ecl.2021.05.013
16. Triñanes J, Rodriguez-Rodriguez AE, Brito-Casillas Y, Wagner A, De Vries AP, Cuesto G, Acebes A, Salido E, Torres A, Porrini E. Deciphering tacrolimus-induced toxicity in pancreatic β cells. American Journal of Transplantation. 2017; Nov 1; 17(11): 2829-40. DOI: https://doi.org/10.1111/ajt.14323
17. Natalicchio A, Tortosa F, Perrini S, Laviola L, Giorgino F. p66Shc, a multifaceted protein linking Erk signalling, glucose metabolism, and oxidative stress. Archives of Physiology and Biochemistry. 2011; Jul 1; 117(3): 116-24. DOI: https://doi.org/10.3109/13813455.2011.562513
18. Bhatti JS, Sehrawat A, Mishra J, Sidhu IS, Navik U, Khullar N, Kumar S, Bhatti GK, Reddy PH. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. Free Radical Biology and Medicine. 2022; May 1; 184: 114-34. DOI: https://doi.org/10.1016/j.freeradbiomed.2022.03.019
19. Sagar SM. Future directions for research on Silybum marianum for cancer patients. Integrative Cancer Therapies. 2007; Jun; 6(2): 166-73. DOI: https://doi.org/10.1177/1534735407301566
20. Jyotsna FN, Ahmed A, Kumar K, Kaur P, Chaudhary MH, Kumar S, Khan E, Khanam B, Shah SU, Varrassi G, Khatri M. Exploring the complex connection between diabetes and cardiovascular disease: analyzing approaches to mitigate cardiovascular risk in patients with diabetes. Cureus. 2023; Aug 21; 15(8). DOI: 10.7759/cureus.43882.
21. Uppara Venkatesh, Dr. B. V. Ramana, Evaluation of the Antidiabetic and antioxidant potential of a Polyherbal Extract in streptozotocin-Induced Diabetes Rats. Eur. Chem. Bull. 2023, 12(10), 10180-10199. Available on: https://www.eurchembull.com/uploads/paper/936401d94ad473016bdd83753042c72f.pdf
22. Lanjhiyana S, Garabadu D, Ahirwar D, Bigoniya P, Rana AC, Patra KC, Lanjhiyana MK, Karuppaih M. Antidiabetic activity of methanolic extract of stem bark of Elaeodendron glaucum Pers. in alloxanized rat model. Adv Appl Sci Res. 2011; 2(1): 47-62.
23. Bessey OA, Lowky OH, Brock MJ. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. Journal of Biological Chemistry. 1946; 164: 321-9.
24. Wright PJ, Leathwood PD, Plummer DT. Enzymes in rat urine: alkaline phosphatase. Enzymologia. 1972; Apr 1; 42(4): 317-27.
25. IFCC (International Federat ion of Clinical Chemist ry), (1980). Physicochemical quantities and units in clinical chemistry. Journal of Clinical Chemistry and Clinical Biochemistry, 18:829-854. DOI: https://doi.org/10.1515/cclm.1980.18.11.829
26. Henry RJ. Clinical chemistry Harber and Row publishers. New York. 1964:181-182.
27. Doumas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin with bromcresol green. Clinica Chimica Acta. 1971; Jan 1; 31(1): 87-96. DOI: https://doi.org/10.1016/0009-8981(71)90365-2
28. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 1949; Feb 1; 177(2): 751-66.
29. Puri SK, Habbu PV, Kulkarni PV, Joshi AB, Kulkarni VH, Dixit SR. Hepatoprotective activity and constituents of Nigrospora sp. CMH2_13: An endophytic fungus isolated from leaves of Phyllanthus amarus Schum. and Thonn. Ann Phytomed. 2020; 9(2): 239-46. DOI: http://dx.doi.org/10.21276/ap.2020.9.2.22
30. Jendrassik L, Grof P. Estimation of total serum bilirubin level by spectrophotometrically in serum and plasma. Biochem Zeitschrift. 1938; 297: 81-9. DOI:10.36462/H.BioSci.202111
31. Fawcett J, Scott J. A rapid and precise method for the determination of urea. Journal of clinical pathology. 1960; Mar 1; 13(2): 156-9. DOI: http://dx.doi.org/10.1136/jcp.13.2.156
32. Natelson S, Scott ML, Beffa C. A rapid method for the estimation of urea in biologic fluids: by means of the reaction between diacetyl and urea. American Journal of Clinical Pathology. 1951; Mar 1; 21(3_ts): 275-81. DOI: https://doi.org/10.1093/ajcp/21.3_ts.275
33. Fossati P, Prencipe L, Berti G. Enzymatic colorimetric method of determination of uric acid in serum. Clin. Chem. 1980; 26(2): 227-73.
34. Brod J, Sirota JH. The renal clearance of endogenous “creatinine” in man. The Journal of Clinical Investigation. 1948; Sep 1; 27(5): 645-54. Available on: https://dm5migu4zj3pb.cloudfront.net/manuscripts/102000/102012/JCI48102012.pdf
35. Mohite M S, Shelar P A, Raje V N., Babar S. J., Sapkal R. K. Review on Pharmacological Properties of Abutilon indicum. Asian J. Pharm. Res. 2012; 2(4): Oct. - Dec. 156-160. DOI: 10.5958/2231–5691
36. R. Selvanayaki, T. Ananthi. Hepatoprotective Activity of Aqueous Extract of Lawsonia inermis against Paracetamol Induced Rats. Asian J. Pharm. Res. 2012; 2(2): April-June 75-77. DOI: 10.5958/2231–5691
37. Amana Parveen, Anju Singh, A. Rajendiran, Sagar Singh Jough, Shivam Kumar Verma. Herbal elicited Hepatoprotection and Hepatotoxicity – A Comprehensive Review. Asian Journal of Pharmaceutical Research. 2022; 12(2): 155-1. DOI: 10.52711/2231-5691.2022.00024
38. Pooja RC, Ajay B V, Bharathi DR. Geomorphology, Phytochemistry, Ethnomedical and Pharmacological activities of Amaranthus viridis Linn. Asian Journal of Pharmaceutical Research. 2023; 13(1): 41-4. DOI:10.52711/2231-5691.2023.00007
39. S. Manokaran, V.S. Saravanan , Y. Bhargavi. Hepatoprotective Activity of Prunus persica Peaches against Paracetamol Induced Hepatotoxicity. Research J. Pharmacognosy and Phytochemistry 2011; 3(2): 75-76. DOI: 10.5958/0975-4385
40. V. Sreedhar, L.K. Ravindra Nath, N. Madana Gopal, K. Venu Gopal, D.Raju, K.K. Rajasekhar. Hepatoprotective Activity of Vitex quinata Roots against Paracetamol-Induced Hepatic Injury in Rats. Research J. Pharmacognosy and Phytochemistry. 2011; 3(2): 77-81. DOI: 10.5958/0975-4385
41. Pushpendra K. Patel, Narendra K. Prajapati, B.K. Dubey. Hepatotoxicity: Causes, Symptoms and Herbal Remedies. Research J. Pharmacognosy and Phytochemistry. 2012; 4(2): 104-111. DOI: 10.5958/0975-4385
42. Pradeep Kumar Samal. Assessment of Hepatoprotective Activity of Strobilanthes asperrimus in Thioacetamide Induced Hepatoxic Rats. Research J. Pharmacognosy and Phytochemistry. 2013; 5(3): 139-142. DOI: 10.5958/0975-4385
43. Ramasamy Arivukkarasu, Aiyalu Rajasekaran, Syed haffan bin hussain, Mohammed Ajnas.Simultaneous detection of Rutin, Quercetin, Gallic acid, Caffeic acid, Ferulic acid, Coumarin, Mangiferin and Catechin in Hepatoprotective commercial herbal formulations by HPTLC technique. Res. J. Pharmacognosy and Phytochem. 2018; 10(1): 59-62. DOI: 10.5958/0975-4385.2018.00009.2
44. Maharaja P, Sengottuvel T, Aarthi A, Gopalasatheeskumar K. Review on Antioxidant and Hepatoprotective activity of Medicinal plants against Paracetamol Induced animal model. Res. J. Pharmacognosy and Phytochem. 2020; 12(2): 114-119. DOI: 10.5958/0975-4385.2020.00020.5
45. Chitra Govind Rajput. Formulation and Evaluation of Fenugreek powder as Nutraceutical from seeds of Trigonella foenum graecum. Research Journal of Pharmacognosy and Phytochemistry. 2021; 13(2):78-0. DOI: 10.52711/0975-4385.2021.00013